On Wednesday, April 22, officials in Germany announced the approval of first clinical trials of a coronavirus vaccine in the country. In a press release, the German regulatory authority Paul-Ehrlich-Institut said that a biotechnology company's vaccine program was authorized for human trials after careful consideration of the potential risks and benefits.